Discontinued drugs — cardiology
Drug development has roughly a 90% failure rate. This tracker catalogues compounds that were halted in clinical development or withdrawn after marketing, with the documented reason and the sponsor. Useful for understanding what's worked vs. what hasn't in a given disease, mechanism, or class.